Uploaded February 2022 | Updated September 2026, 2 weeks ago
“Heartbeat of Dementia Care” by Serggio Lanata, MD, MS
Objectives
• Identify at least three basic brain structures and functions
• Describe at least three ways the brain changes with aging
• Define the term “dementia” and describe at least three signs and symptoms associated with common causes of dementia
• Provide an overview of the diagnostic process for a person with cognitive concerns
“Hopeful Advances in Research” by Lawren Vandevrede, MD, PhD
Objectives
• Discuss clinical trial evidence behind FDA approval of aducanumab
• Identify at least two safety concerns associated with aducanumab and two considerations for appropriate clinical use post-approval
Dr. Serggio Lanata is a neurologist who cares for patients with cognitive impairment. His research focuses on improving treatment for Alzheimer’s disease in underserved and underrepresented communities. He studies how social determinants of health — factors such as income level and traumatic life experiences — affect brain health and cognition. The goal is to identify risk factors that lead to cognitive decline. After completing a biological sciences program at the Universidad Ricardo Palma in Lima, Peru, Lanata earned his bachelor’s degree in food science and human nutrition at the University of Florida. He then earned a master’s degree in physiology, complementary and alternative medicine at Georgetown University before earning his medical degree from the University of South Florida Morsani College of Medicine. He completed a residency in neurology at Brown University and a fellowship in behavioral neurology at UCSF.
As an Assistant Professor and cognitive neurologist at UCSF, Dr. Lawren VandeVrede’s primary goal is to provide outstanding clinical care to patients with dementia and their caregivers. He completed his medical training in Chicago, where he also obtained a PhD degree in neuroscience in preclinical drug development for Alzheimer’s disease. He completed his residency in the Harvard Neurology Residency program, and he received fellowship training at the UCSF Memory and Aging Center. His research interests are in advancing novel diagnostic and therapeutic tools from the research world into the clinic, especially new blood tests for neurodegenerative disease.
“Heartbeat of Dementia Care” by Serggio Lanata, MD, MS
Objectives
• Identify at least three basic brain structures and functions
• Describe at least three ways the brain changes with aging
• Define the term “dementia” and describe at least three signs and symptoms associated with common causes of dementia
• Provide an overview of the diagnostic process for a person with cognitive concerns
“Hopeful Advances in Research” by Lawren Vandevrede, MD, PhD
Objectives
• Discuss clinical trial evidence behind FDA approval of aducanumab
• Identify at least two safety concerns associated with aducanumab and two considerations for appropriate clinical use post-approval
Dr. Serggio Lanata is a neurologist who cares for patients with cognitive impairment. His research focuses on improving treatment for Alzheimer’s disease in underserved and underrepresented communities. He studies how social determinants of health — factors such as income level and traumatic life experiences — affect brain health and cognition. The goal is to identify risk factors that lead to cognitive decline. After completing a biological sciences program at the Universidad Ricardo Palma in Lima, Peru, Lanata earned his bachelor’s degree in food science and human nutrition at the University of Florida. He then earned a master’s degree in physiology, complementary and alternative medicine at Georgetown University before earning his medical degree from the University of South Florida Morsani College of Medicine. He completed a residency in neurology at Brown University and a fellowship in behavioral neurology at UCSF.
As an Assistant Professor and cognitive neurologist at UCSF, Dr. Lawren VandeVrede’s primary goal is to provide outstanding clinical care to patients with dementia and their caregivers. He completed his medical training in Chicago, where he also obtained a PhD degree in neuroscience in preclinical drug development for Alzheimer’s disease. He completed his residency in the Harvard Neurology Residency program, and he received fellowship training at the UCSF Memory and Aging Center. His research interests are in advancing novel diagnostic and therapeutic tools from the research world into the clinic, especially new blood tests for neurodegenerative disease.
